Literature DB >> 29506182

Consecutive operative procedures in patients with Marfan syndrome up to 28 years after initial aortic root surgery.

Nazan Puluca1,2, Melchior Burri1,2, Julie Cleuziou1,2, Markus Krane1,2,3, Rüdiger Lange1,2,3.   

Abstract

OBJECTIVES: Most patients (75%) with Marfan syndrome present with aortic root dilatation that may require surgical intervention. However, associated cardiovascular disorders are not limited to the aortic root. These patients frequently require consecutive operations on the remaining thoracic aorta or the heart valves. Our intent was to characterize the spectrum of such procedures.
METHODS: Data from all patients with Marfan syndrome undergoing aortic root surgery at our centre between 1988 and 2016 were analysed retrospectively.
RESULTS: Overall, 73 patients (26 women) were selected for the study. The median age at 1st operation was 30 years (3-68 years). Indications for aortic root surgery were aneurysm (78%) and dissection (22%). Initially, 33 Bentall procedures and 40 valve-sparing root replacement procedures were performed, with a 97% rate of follow-up completion. The median follow up was 8 years (0-28 years). Survival at 1, 10 and 15 years was 100%, 85% and 82%, respectively. During follow-up monitoring, 48 subsequent procedures were performed in 33 patients (aorta, 23; aortic valve, 11; mitral valve, 7 and combined procedures, 7). The 30-day mortality rate after subsequent procedures was 4.2%. Freedom from subsequent operation and death (combined end-point) after 5, 10 and 15 years was 70%, 53% and 34%, respectively.
CONCLUSIONS: After the initial surgery, subsequent procedures required in the setting of Marfan syndrome most often involve the remaining native aorta, followed by the aortic and mitral valves. The continued need for additional operative procedures remains high, even decades after the initial surgeries are undertaken. Therefore, long-term patient monitoring at specialized centres is imperative.

Entities:  

Mesh:

Year:  2018        PMID: 29506182     DOI: 10.1093/ejcts/ezy065

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  6 in total

1.  Long-Term Outcomes after Aortic Valve and Root Replacement in a Very High-Risk Population.

Authors:  Jan Hlavicka; Kiril Antonov; Razan Salem; Florian Hecker; Spiros Marinos; Medhat Radwan; Fabian Emrich; Arnaud Van Linden; Anton Moritz; Thomas Walther; Tomas Holubec
Journal:  J Cardiovasc Dev Dis       Date:  2022-06-20

Review 2.  Imaging of the Postsurgical Aorta in Marfan Syndrome.

Authors:  Lauren K Groner; Christopher Lau; Richard B Devereux; Daniel B Green
Journal:  Curr Treat Options Cardiovasc Med       Date:  2018-08-27

3.  Decision-making at initial surgery for type A aortic dissection in patients with Marfan syndrome: proximal or extensive repair.

Authors:  Ning Li; Yu Zhang; Yuan Gao; Yifan Bai; Zhao An; Guanxin Zhang; Qingqi Han; Fanglin Lu; BaiLing Li; Lin Han; Zhiyun Xu
Journal:  J Thorac Dis       Date:  2019-12       Impact factor: 2.895

4.  Survival, causes of death, and cardiovascular events in patients with Marfan syndrome.

Authors:  Thy Thy Vanem; Odd Ragnar Geiran; Kirsten Krohg-Sørensen; Cecilie Røe; Benedicte Paus; Svend Rand-Hendriksen
Journal:  Mol Genet Genomic Med       Date:  2018-11-04       Impact factor: 2.183

5.  Efficacy of cardiovascular surgery for Marfan syndrome patients: a single-center 15-year follow-up study.

Authors:  Boyao Zhang; Qing Xue; Yangfeng Tang; Shangyi Yu; Xingli Fan; Zhiyun Xu; Lin Han
Journal:  J Thorac Dis       Date:  2020-12       Impact factor: 2.895

6.  Long-term outcomes of surgical procedures for Marfan syndrome: aortic dissection versus aneurysm.

Authors:  Ning Li; Yu Zhang; Yuan Gao; Yifan Bai; Fan Qiao; Mengwei Tan; Qingqi Han; Fanglin Lu; Bailing Li; Lin Han; Guanxin Zhang; Zhiyun Xu
Journal:  J Thorac Dis       Date:  2020-03       Impact factor: 3.005

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.